Evidence map›Paper›PMID 21303971›Full record

ArticleCancer research2011

PIPKIγ regulates β-catenin transcriptional activity downstream of growth factor receptor signaling.

Mark Schramp, Narendra Thapa, Jessica Heck, Richard Anderson

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. PI(4,5)PScience advances · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  10. IQGAP1 is a phosphoinositide effector and kinase scaffold.Advances in biological regulation · 2016
    Review
  11. Article
  12. Article
  13. Article
  14. Phosphatidylinositol 4,5-bisphosphate: targeted production and signaling.BioEssays : news and reviews in molecular, cellular and developmental biology · 2013
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mark SchrampDepartment of Pharmacology, School of Medicine and Public Health, and Program in Molecular and Cellular Pharmacology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Narendra Thapa
Jessica Heck
Richard Anderson
University of Wisconsin–Madison · US

Funding

Targeting of Phosphoinositide Signaling in Migration, Invasion and MetastasisR01GM057549 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI ANDERSON, RICHARD A. · 1998 to 2019
$5.7M
PHOSPHOINOSITIDE SIGNALING TO AND WITHIN THE NUCLEUSR01GM051968 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI ANDERSON, RICHARD A. · 1995 to 2012
$3.2M
PI Signaling Role in Epithelial/Mesenchymal TransitionR01CA104708 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI ANDERSON, RICHARD A. · 2004 to 2014
$2.9M
Nuclear Phosphoinositide Control of 3'-end mRNA Processing and Gene ExpressionR01GM114386 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI ANDERSON, RICHARD A. · 2016 to 2019
$1.5M
NCI NIH HHS CA104708NCI NIH HHS R01 CA104708NIGMS NIH HHS GM051968NIGMS NIH HHS GM057549NIGMS NIH HHS R01 GM051968NIGMS NIH HHS R01 GM057549NIGMS NIH HHS R01 GM114386
6 · The paper itself

Abstract

Increased β-catenin transcriptional activity downstream of the Wnt/Wingless signaling pathway has been observed in many human tumors, most notably colorectal carcinomas. However, β-catenin activation is also observed in many human malignancies with no observable Wnt activity. Wnt-independent pathways that activate β-catenin remain undefined, yet have the potential to play a significant role during tumorigenesis. Here, we report that phosphotidylinositol phosphate kinase Iγ (PIPKIγ), an enzyme that generates phosphoinositide messengers in vivo, directly associates with β-catenin and increases β-catenin activity downstream of growth factor stimulation. PIPKIγ expression and kinase activity enhance β-catenin phosphorylation on residues that promote nuclear importation and transcriptional activity. Lastly, we show that β-catenin is required for PIPKIγ-dependent increased cell proliferation. These results reveal a novel mechanism in which PIPKIγ expression and catalytic activity enhance β-catenin nuclear translocation and expression of its target genes to promote tumorigenic phenotypes.

Indexed as

Transcriptional Activationbeta CateninCadherinsCell NucleusCell Transformation, NeoplasticGene Expression Regulation, NeoplasticGene Knockdown TechniquesHeLa CellsHumansPhosphotransferases (Alcohol Group Acceptor)Protein TransportReceptors, Growth FactorRNA, Small InterferingSignal TransductionTranscription, GeneticTransfection1-phosphatidylinositol-4-phosphate 5-kinasebeta CateninCadherinsPhosphotransferases (Alcohol Group Acceptor)Receptors, Growth FactorRNA, Small Interfering

Identifiers

PMID21303971
PMCPMC3066690
OpenAlexW2152173937

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.